(Q79291837)

English

Polymorphisms and the Pocketbook: The Cost‐Effectiveness of Cytochrome P450 2C19 Genotyping in the Eradication of Helicobacter pylori Infection Associated with Duodenal Ulcer

scientific article published on 01 December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615467%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Polymorphisms and the pocketbook: the cost-effectiveness of cytochrome P450 2C19 genotyping in the eradication of Helicobacter pylori infection associated with duodenal ulcer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615467%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Polymorphisms and the Pocketbook: The Cost‐Effectiveness of Cytochrome P450 2C19 Genotyping in the Eradication of Helicobacter pylori Infection Associated with Duodenal Ulcer (English)

1 reference

10.1177/0091270003259389

https://api.crossref.org/works/10.1177/0091270003259389

1 April 2024

Helicobacter pylori

1 reference

based on heuristic

inferred from title

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

1 reference

10.1177/0091270003259389

https://api.crossref.org/works/10.1177/0091270003259389

1 April 2024

author name string

David F. Lehmann

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615467

1 April 2024

Joseph J. Medicis

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615467

1 April 2024

Patricia D. Franklin

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615467

1 April 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14615467

1 April 2024

publication date

1 December 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615467%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270003259389

1 reference

10.1177/0091270003259389

https://api.crossref.org/works/10.1177/0091270003259389

1 April 2024

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1177/0091270003259389

1 reference

10.1177/0091270003259389

https://api.crossref.org/works/10.1177/0091270003259389

1 April 2024

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615467%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

43

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615467%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615467%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1316-1323

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615467%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

A comparison of omeprazole and placebo for bleeding peptic ulcer

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

How to correctly calculate the proportions of the heterozygotes and homozygotes in the extensive metabolizers of a certain drug-metabolizing enzyme in an ethnic or racial population?

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Genetic analysis of the S-mephenytoin polymorphism in a Chinese population

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Genetic polymorphism of debrisoquine (CYP2D6) and proguanil (CYP2C19) in South Pacific Polynesian populations

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Dapsone N-acetylation, metoprolol alpha-hydroxylation, and S-mephenytoin 4-hydroxylation polymorphisms in an Indonesian population: a cocktail and extended phenotyping assessment trial

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Racial differences in the response to drugs--pointers to genetic differences

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F0091270003259389

21 January 2018

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations

37

1 reference

10.1177/0091270003259389

https://api.crossref.org/works/10.1177/0091270003259389

1 April 2024

Identifiers

10.1177/0091270003259389

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615467%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14615467%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79291837&oldid=2116453662"